Pharmagen, Inc.

Equities

PHRX

US71715W1062

Market Closed - OTC Markets Other stock markets 14:57:23 22/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Pharmagen, Inc. Announces Consolidated Earnings Results for the Fiscal Year Ended December 31, 2012

April 01, 2013 at 07:00 pm

Pharmagen, Inc. announced consolidated earnings results for the fiscal year ended December 31, 2012. For the year, the company's net revenues totaled $4,260,000 compared to net revenues of $863,000, representing 490% growth year-over-year. The company spent much of 2012 building the cornerstones for a move toward profitability in 2013.

Latest news about Pharmagen, Inc.

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	29/11/15	CI
Pharmagen, Inc. Announces Management Changes	02/07/14	CI
Pharmagen, Inc. Announces Executive Changes	11/06/14	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	11/06/14	CI
Pharmagen Appoints Additional Members to its Board of Directors	29/05/14	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	06/05/14	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	29/04/14	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	31/03/14	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	24/02/14	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	24/02/14	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	17/12/13	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	11/12/13	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	14/11/13	CI
Pharmagen Seeks Acquisitions	31/10/13	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	09/08/13	CI
Pharmagen, Inc. announced that it expects to receive $0.04 million in funding from Asher Enterprises, Inc.	01/08/13	CI
Pharmagen, Inc. announced that it has received $0.06 million in funding from Asher Enterprises, Inc.	19/06/13	CI
Pharmagen, Inc. announced that it expects to receive $0.06 million in funding from Asher Enterprises, Inc.	05/06/13	CI
Pharmagen, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2013	15/05/13	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Fiscal Year Ended December 31, 2012	01/04/13	CI
Pharmagen, Inc. announced that it has received $0.60 million in funding from Trafalgar Capital Advisors LTD.	29/03/13	CI
Pharmagen, Inc. announced that it expects to receive $2 million in funding from Trafalgar Capital Advisors LTD.	28/02/13	CI
Sunpeaks Ventures, Inc. will Change its Ticker to PHRX from SNPK	15/01/13	CI
Sunpeaks Ventures, Inc. Creates New Operating Unit, Pharmagen Nutraceuticals	14/01/13	CI
Sunpeaks Ventures, Inc. has Changed its Name to Pharmagen, Inc	14/01/13	CI

Chart Pharmagen, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company